In small cell lung cancer (SCLC), for example, the prevalence of RB1 loss is more than 90% [12,13], while RB1 function in cervical cancer is suppressed by directly associating with HPV-E7 oncoprotein at a frequency of at least 90% [14,15]. This evidence concerns the gene RB1 and cervical cancer.